We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kooth Plc | KOO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 17.50 | 10.77% | 180.00 | 09:39:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 168.50 | 168.50 | 180.00 | 180.00 | 162.50 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 11/1/2024 16:41 by rimau1 They have dealt with this before on investor calls as they get this question a lot. The CFO wants to be treated as a hybrid SAAS so not a typical pure SAAS, so i interpret that as a valuation metric of ARR x 3-4x rather than a SAAS of ARR 5-10x |
Posted at 02/10/2023 11:37 by rimau1 Excellent investor call this morning and they answered all my questions. Cali is on track for go-live. News on Penn expansion and potentially formal contract award expected in Q4. Laser focussed on Cali delivery, pilot in 2 communities is live, all 19 languages on track. They will then bring the Cali technology back to the UK to upgrade the UK tech which is great news. Expecting at least one new US state award in 2024 but no news on this in 2023. Hopefully Penn large contrsct award incoming. |
Posted at 16/7/2023 09:45 by rimau1 Broker note from Liberum - consistent with my valuation assumptions posted last week.Koo, a front-runner in the personalised digital mental health sector, could offer a significant value proposition for investors, according to a recent note by UK brokerage firm Liberum. The company's shares, currently priced at 346p, are undervalued based on Liberum's price target of 457p. But the growth potential doesn't stop there. Liberum points to the potential for more US contracts and licensing opportunities, which could add a further 400p over time, effectively more than doubling the company's share price. The timing couldn't be better for Kooth, as it enters the fray in a world grappling with a mental health crisis. It's one of the few companies with a proven solution to address this, and it's already a market leader in the UK. Recently, the company managed to secure transformational contracts in the US, worth $180 million and indicating its scalability and potential for international expansion. The California deal is a prime example of this, which could potentially triple Kooth's revenue. As the company moves forward, key value drivers will include technology updates for the California contract, scaling up in Pennsylvania and California, and renewing the Pennsylvania contract. However, it should be noted that there is a high execution risk over the next twelve months. Liberum emphasises what the market might be overlooking. The breadth and scalability of Kooth's offerings are difficult to replicate, making it a unique player in the sector. Licensing will also enable Kooth to scale rapidly and with less risk. |
Posted at 04/7/2023 06:13 by rimau1 Wow, that is way, way beyond my expectations. Smart to raise funds as buffer given the significant upfront opex and capex. Even better news; Kooth have also identified further opportunities in the US for expansion. I am guessing New York state. In earlier investor calls they downplayed further state expansion wanting to concentrate on Cali and Penn. Hold til you’re old. |
Posted at 17/4/2023 08:14 by rimau1 Investor meet presentation this morning, hopefully some meet on the bones of the Cali contract, a Penn update and wider US update. Nice rise this morning in anticipation or maybe a cheeky RNS pre 11am! |
Posted at 12/4/2023 10:08 by rimau1 Thanks for the replies both. I had not seen the article on the Penn progress, i think we are guaranteed to evolve the pilot scheme into something larger now. I did know New York and NC are next on the hitlist. This is all very encouraging, each state that successfully rolls this out sets a precedent for other states to follow. Maybe we will get a first hand update at the upcoming investor meet presentation. Exciting times and nice to invest in something that provides tangible good. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
